250 related articles for article (PubMed ID: 34502278)
41. Patient-derived xenograft model engraftment predicts poor prognosis after surgery in patients with pancreatic cancer.
Chen Q; Wei T; Wang J; Zhang Q; Li J; Zhang J; Ni L; Wang Y; Bai X; Liang T
Pancreatology; 2020 Apr; 20(3):485-492. PubMed ID: 32113935
[TBL] [Abstract][Full Text] [Related]
42. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
Heo EJ; Cho YJ; Cho WC; Hong JE; Jeon HK; Oh DY; Choi YL; Song SY; Choi JJ; Bae DS; Lee YY; Choi CH; Kim TJ; Park WY; Kim BG; Lee JW
Cancer Res Treat; 2017 Oct; 49(4):915-926. PubMed ID: 28052650
[TBL] [Abstract][Full Text] [Related]
43. An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer.
Gitto SB; Kim H; Rafail S; Omran DK; Medvedev S; Kinose Y; Rodriguez-Garcia A; Flowers AJ; Xu H; Schwartz LE; Powell DJ; Simpkins F
Gynecol Oncol; 2020 Jan; 156(1):222-232. PubMed ID: 31818495
[TBL] [Abstract][Full Text] [Related]
44. Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft.
Landuzzi L; Palladini A; Ceccarelli C; Asioli S; Nicoletti G; Giusti V; Ruzzi F; Ianzano ML; Scalambra L; Laranga R; Balboni T; Arigoni M; Olivero M; Calogero RA; De Giovanni C; Dall'Ora M; Di Oto E; Santini D; Foschini MP; Cucchi MC; Zanotti S; Taffurelli M; Nanni P; Lollini PL
Sci Rep; 2021 Jan; 11(1):1563. PubMed ID: 33452364
[TBL] [Abstract][Full Text] [Related]
45. Establishment of a patient-derived orthotopic Xenograft (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern.
Hiroshima Y; Zhang Y; Zhang N; Maawy A; Mii S; Yamamoto M; Uehara F; Miwa S; Yano S; Murakami T; Momiyama M; Chishima T; Tanaka K; Ichikawa Y; Bouvet M; Murata T; Endo I; Hoffman RM
PLoS One; 2015; 10(2):e0117417. PubMed ID: 25689852
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.
Xu W; Zhao ZY; An QM; Dong B; Lv A; Li CP; Guan XY; Tian XY; Wu JH; Hao CY
Int J Med Sci; 2020; 17(18):3073-3081. PubMed ID: 33173428
[TBL] [Abstract][Full Text] [Related]
47. Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas.
Castillo-Ecija H; Pascual-Pasto G; Perez-Jaume S; Resa-Pares C; Vila-Ubach M; Monterrubio C; Jimenez-Cabaco A; Baulenas-Farres M; Muñoz-Aznar O; Salvador N; Cuadrado-Vilanova M; Olaciregui NG; Balaguer-Lluna L; Burgueño V; Vicario FJ; Manzanares A; Castañeda A; Santa-Maria V; Cruz O; Celis V; Morales La Madrid A; Garraus M; Gorostegui M; Vancells M; Carrasco R; Krauel L; Torner F; Suñol M; Lavarino C; Mora J; Carcaboso AM
J Pathol Clin Res; 2021 Jul; 7(4):338-349. PubMed ID: 33837665
[TBL] [Abstract][Full Text] [Related]
48. EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models.
Martins-Filho SN; Weiss J; Pham NA; Li Q; Cabanero M; Fares A; Stewart EL; Shi R; Patel D; Pal P; McConnell J; Bradbury PA; Sacher AG; Leighl NB; Grindlay A; Allison F; Li M; Yasufuku K; Shepherd FA; Moghal N; Tsao MS; Liu G
Lung Cancer; 2020 Jul; 145():144-151. PubMed ID: 32447118
[TBL] [Abstract][Full Text] [Related]
49. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review.
Jin K; Teng L; Shen Y; He K; Xu Z; Li G
Clin Transl Oncol; 2010 Jul; 12(7):473-80. PubMed ID: 20615824
[TBL] [Abstract][Full Text] [Related]
50. Patient-Derived Orthotopic Xenograft models in gastric cancer: a systematic review.
Reddavid R; Corso S; Moya-Rull D; Giordano S; Degiuli M
Updates Surg; 2020 Dec; 72(4):951-966. PubMed ID: 32253687
[TBL] [Abstract][Full Text] [Related]
51. Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study.
Jiang Y; Zhao J; Zhang Y; Li K; Li T; Chen X; Zhao S; Zhao S; Liu K; Dong Z
J Transl Med; 2018 May; 16(1):138. PubMed ID: 29788985
[TBL] [Abstract][Full Text] [Related]
52. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
53. Creation and characterization of a xenograft model for human cervical cancer.
Hoffmann C; Bachran C; Stanke J; Elezkurtaj S; Kaufmann AM; Fuchs H; Loddenkemper C; Schneider A; Cichon G
Gynecol Oncol; 2010 Jul; 118(1):76-80. PubMed ID: 20441999
[TBL] [Abstract][Full Text] [Related]
54. Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer.
Fang T; Huang H; Li X; Liao J; Yang Z; Hoffman RM; Cheng XI; Liang L; Hu W; Yun S
Anticancer Res; 2018 Jan; 38(1):179-186. PubMed ID: 29277771
[TBL] [Abstract][Full Text] [Related]
55. Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
Dobrolecki LE; Airhart SD; Alferez DG; Aparicio S; Behbod F; Bentires-Alj M; Brisken C; Bult CJ; Cai S; Clarke RB; Dowst H; Ellis MJ; Gonzalez-Suarez E; Iggo RD; Kabos P; Li S; Lindeman GJ; Marangoni E; McCoy A; Meric-Bernstam F; Piwnica-Worms H; Poupon MF; Reis-Filho J; Sartorius CA; Scabia V; Sflomos G; Tu Y; Vaillant F; Visvader JE; Welm A; Wicha MS; Lewis MT
Cancer Metastasis Rev; 2016 Dec; 35(4):547-573. PubMed ID: 28025748
[TBL] [Abstract][Full Text] [Related]
56. The Tumor Growth Inhibitory Effect of a Standardized Extract of Cultured Lentinula edodes Mycelia Using Patient Derived Xenograft Model.
Yoshii R; Adachi S; Ryo H; Hatanaka E; Yasuda K; Kaji M; Enomoto K; Takanari J; Yoshidome K; Nomura T; Tomiyama N
Biol Pharm Bull; 2024; 47(2):532-538. PubMed ID: 38417905
[TBL] [Abstract][Full Text] [Related]
57. Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review.
Brown KM; Xue A; Mittal A; Samra JS; Smith R; Hugh TJ
Oncotarget; 2016 Oct; 7(40):66212-66225. PubMed ID: 27517155
[TBL] [Abstract][Full Text] [Related]
58. [Establishment and its biological characteristics of patient-derived lung cancer xenograft models].
Zhuo Y; Wu Y; Guo A; Chen S; Su J
Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):568-74. PubMed ID: 20681441
[TBL] [Abstract][Full Text] [Related]
59. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.
Guo S; Gao S; Liu R; Shen J; Shi X; Bai S; Wang H; Zheng K; Shao Z; Liang C; Peng S; Jin G
FASEB J; 2019 Jan; 33(1):873-884. PubMed ID: 30091943
[TBL] [Abstract][Full Text] [Related]
60. Translational pancreatic cancer research: A comparative study on patient-derived xenograft models.
Rubio-Manzanares Dorado M; Marín Gómez LM; Aparicio Sánchez D; Pereira Arenas S; Praena-Fernández JM; Borrero Martín JJ; Farfán López F; Gómez Bravo MÁ; Muntané Relat J; Padillo Ruiz J
World J Gastroenterol; 2018 Feb; 24(7):794-809. PubMed ID: 29467550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
